1. Home
  2. study

[jubilee bachelor]/C O R R E C T I O N — BioHarvest Sciences Inchttps://investingnews.com/daily/cannabis-investing/aur

  Investing News Network

  July 26 | 2021

  Distinguished senior healthcare executive, Theresa Firestone , to fill newly added position

  NASDAQ | TSX: ACB

  Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the appointment of Theresa Firestone to the Company’s Board of Directors (the “Board”), effective today. This is a newly created directorship that expands the Board to nine members, seven of whom are independent.

  Theresa Firestone joins the Board of Directors of Aurora Cannabis (CNW Group/Aurora Cannabis Inc.)

  Ms. Firestone joins the Board following a distinguished career as a senior healthcare executive with leadership positions in Canada , Europe and Asia . An expert in strategic planning, operations and new business development, Ms. Firestone has served in various sectors such as retail, healthcare, pharmaceuticals and government. Her experience includes over 20 years of international P&L management, 15 years in senior roles at Pfizer Inc., over ten years at the Ontario Ministry of Health and seven years in retail and health and wellness, including Shoppers Drug Mart where she oversaw the design and launch of the company’s Medical Cannabis business. In addition, Ms. Firestone has more than 20 years of public and private board experience including with Orion Biotechnology, Merus Labs International and several not-for-profit organizations.

  Ronald Funk , Chairman of Aurora Cannabis stated, “We are delighted to welcome Theresa to our Board of Directors.? She brings to us extensive expertise in healthcare management and pharmaceuticals, global business restructuring, new business development and a proven ability to lead and manage change. Her background and well-defined skillset will be invaluable to us as we execute our strategic growth plans while managing costs more effectively. We look forward to benefitting from her many contributions to Aurora.”

  Ms. Firestone holds a Bachelor of Applied Science from the University of Guelph and completed the Executive Leadership Program at Harvard Business School . Accolades include induction into the Canadian Healthcare Marketing Hall of Fame, honoured as one of 12 Outstanding Canadian Women by the Weizman Institute and awarded the prestigious Queen’s Golden Jubilee medal.

  About Aurora

  Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .

  Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB” and is a constituent of the S&P/TSX Composite Index.

  Forward-looking Information

  This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements? made in this news release include statements regarding the Company’s execution of strategic growth plans while managing costs. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated September 24, 2020 (the “AIF”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov . The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

  Aurora Cannabis Logo (CNW Group/Aurora Cannabis Inc.)

  Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-cannabis-announces-appointment-of-new-independent-director-301340664.html

  SOURCE Aurora Cannabis Inc.

  

  Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2021/26/c6026.html

  News Provided by Canada Newswire via QuoteMedia

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  Investing News Network

  July 08 | 2021

  Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

  “We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

  MNP’s resignation was not the result of any disagreement between the Company and MNP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure.? There were no reservations or modified opinions in MNP’s audit reports for the Company. There are no “reportable events” (as the term is defined in National Instrument 51-102 – Continuous Disclosure Obligations (” NI 51-102 “)) between the Company and the Former Auditor. In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the board of directors of the Company and filed on SEDAR.

  About Trulieve

  Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve (through its wholly owned subsidiaries) holds licenses to operate in California , Massachusetts , Pennsylvania , Connecticut , and West Virginia . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.?Learn more at: www.trulieve.com/

  Forward-Looking Statements

  This news release includes forward-looking information and statements within the meaning of the Private Securities Litigation Reform Act of 1995.? These forward-looking statements relate to the Company’s expectations or forecasts of business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs and include statements regarding the equity acquisition of Anna Holdings, LLC.? Words such as “expects”, “continue”, “will”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking statements.?These forward-looking statements are based on the Company’s current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein, including, without limitation, the risks discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and in subsequent periodic and current reports filed with the United Sates Securities and Exchange Commission and in the Company’s filings on SEDAR at www.sedar.com . Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof and, except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise.

  SOURCE Trulieve Cannabis Corp.

  

  Cision View original content: http://www.newswire.ca/en/releases/archive/July2021/07/c9736.html

  News Provided by Canada Newswire via QuoteMedia

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  Keep reading…

  Show less

  Bryan Mc Govern

  July 07 | 2021

  Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

  Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

  But it hasn’t been an easy task to set up a vibrant beverages market that can prove its worth to the cannabis producers keen on cementing the status of drinkable options.

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  Industry insiders have pointed to brand appeal and marketing challenges in the Canadian market as key reasons beverages haven’t taken off in the country just yet.

  Emily Paxhia, co-founder and managing director with well-known cannabis investment fund Poseidon Asset Management, said beverages will be a key part of the industry’s future, particularly when it comes to reaching a new consumer base that may not feel comfortable with smokable or edible products.

  However, the US-focused investor was quick to point out that at the moment this category represents an “incredibly tiny” part of the overall cannabis product market.

  “I do think we have a ways to go before that is a dominant form factor,” Paxhia told the Investing News Network (INN).

  At least for the time being, data shows consumers are still not entirely sold on cannabis beverages. A study conducted by the Dalhousie University Agri-Food Analytics Lab in Halifax found only 4 percent of cannabis consumers in Canada picked drinks as their top choice.

  The study was done to determine consumer enthusiasm for edible and other infused products in Canada by evaluating over 1,000 cannabis consumers across the country.

  According to the study, Canadian consumers overall seem less interested in the edible and infused category. “Twenty-five per cent of cannabis consumers say they typically prefer edibles, down from 36 per cent in 2019,” Dr. Sylvain Charlebois, senior director at the Dalhousie University Agri-Food Analytics Lab, told 660 News in June 2021.

  Similarly, a report by cannabis analytics firm Headset found that in Canada, cannabis beverages have only commanded a market share of 1 to 1.5 percent since January 2020.

  When it comes to the percentage of cannabis drinks inside any given purchase, beverages didn’t fare that much better. By the end of summer 2020, a rise had stabilized at 4.5 percent in terms of cannabis transactions containing a cannabis drink.

  However, the data is encouraging in showing the incremental growth of new consumers who are willing, little by little, to give cannabis beverages a try.

  As part of an annual market evaluation report, the Ontario Cannabis Store (OCS) revealed sales numbers for cannabis drinks in the province. Beverage sales amounted to C$12.8 million from April 2020 to the end of March 2021, accounting for 1.5 percent of the province’s sales.

  Also of note is that the OCS indicated that sales of cannabis drinks were higher at retail stores than through its own online portal.

  Looking at what companies came out on top for beverage sales, the OCS pointed to Tweed, the cannabis brand from Canopy Growth (NASDAQ:CGC,TSX:WEED), as the leading drinks brand in the province.

  Tied in second and third place were Everie, a brand put forth by Fluent Beverages, a joint venture set up between Tilray (NASDAQ:TLRY,TSX:TLRY) and AB InBev (NYSE:BUD), and Houseplant, the Seth Green cannabis brand associated with Canopy Growth.

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  It’s clear though that the current numbers on beverages in the Canadian market still have some catching up to do with the lofty expectations and excitement from members of the industry.

  In 2019, Deloitte estimated cannabis drinks would amount to C$529 million in sales per year for the Canadian market. This projection was part of a total worth of C$2.7 billion for the entire edibles and extracted product category.

  As part of the report’s announcement, author Jennifer Lee, a partner at Deloitte and at the time the firm’s cannabis leader for Canada, said cannabis beverages would be so popular that they could threaten the market cap of alcoholic beverages.

  The report was prepared in the lead-up to the legalization of the “Cannabis 2.0” product category, meaning edibles and infused items. The federal government elected to delay the legalization of these items until a year after official recreational cannabis legalization.

  The Valens Company (TSX:VLNS,OTCQX:VLNCF) has two cannabis drinks currently available, and according to an executive, the company is encouraged for what’s to come with this category.

  Jeff Fallows, president of Valens, told INN the firm aims to open a beverage facility in Ontario this year.

  The executive said he thinks consumers are looking for a better overall experience when it comes to cannabis drinks, particularly in terms of the variety of products.

  “I think you’re starting to see some better products on the market now,” said Fallows. “And I also think you’re starting to see better variety, flavors, profiles, types of beverages.”

  Fallows said he believes the current consumer base is looking for more potent drinks given their established relationship with cannabis.

  “I think that has a lot to do with the profile of the consumer in the market right now — they still are largely the cannabis-friendly type of consumer that is either already or historically has had exposure to cannabis,” he said.

  From his perspective, Valens’ technological progress in the beverage-making process will also help broaden the reach of cannabis drinks. As he explained it, better emulsion technology allows for the masking of flavor profiles related to cannabis.

  Fallows argued that the taste experience for beverages needs to be refined and more closely aligned with the wide availability of flavors from the general beverage market.

  For beverages, “the taste profile impacts the experience more,” he said.

  Despite the promise of refined beverage products, they are still struggling to find a steady audience. One of the biggest obstacles may be the branding rules still surrounding cannabis in Canada.

  Companies continue to lament the Canadian government’s strict decisions on marketing regulations and the way brands are allowed to promote cannabis products in the country.

  Last year, a dispensary owner in Toronto penned a letter explaining that retailers feel restricted in how they talk about products to consumers.

  “We’re highly regulated, there are a lot of limitations to what we can and cannot do in developing and promoting a brand,” said Leah Thiel, vice president of marketing at Indiva (TSXV:NDVA,OTCQX:NDVAF).

  Fallows told INN cannabis beverage makers in Canada can’t guide consumers on how to best integrate these drinks into their lives in the same way the alcohol industry can.

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  “That’s the advantage that will come when we have more flexibility from a marketing or advertising perspective, because you can help the consumer sort through when and how a cannabis beverage makes sense,” the Valens executive said.

  As it stands, Fallows sees the market operating as defined by user experiences based on drink taste and effectiveness. Some of that user experience will be primarily driven by recommendations from budtenders at stores, according to one cannabis beverage maker executive.

  “The budtenders are critical,” Marcello Leone, chairman and CEO of BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF), told INN.

  Leone also sees problems with Canadian cannabis promotion regulations, and expressed his frustrations about what he considers challenging conditions for his products.

  One of the ways to combat that for the time being, according to Leone, is for companies to have supreme confidence in their consumer education efforts, retail partners and budtenders, who are a starting point for the uninitiated in the regulated cannabis market.

  “As a brand, a business has to have a strong retail sales team that can articulate clearly your products and can get everybody very familiarized with your product,” Leone said.

  Truss Beverages, the joint venture set up by HEXO (NYSE:HEXO,TSX:HEXO) and Molson Coors Canada, recently pointed to the summer as a critical moment in time for the progress of cannabis-infused drinks.

  The company proudly announced it expects this time period to represent a key moment in which consumers “embrace cannabis beverages throughout the summer of 2021 and beyond.”

  Lori Hatcher, the head of marketing at Truss Beverage, said the summer period represents a “huge buying opportunity” for all cannabis drinks.

  “We’ve worked in close collaboration with our community of consumers and budtenders to bring together a selection of fresh, new beverages made with natural flavours that are perfect for those outdoor summer occasions,” Hatcher said.

  When asked about what’s missing for cannabis beverages to take off in Canada, Leone went big with his request and told INN he wants to see a not-so-revolutionary concept — a retail lounge space in which consumers can safely consume and explore their choices with cannabis drinks. Sound familiar?

  “We’re in the early days of the end of prohibition of cannabis and cannabis beverages,” he said. “We need the social adoption and social consumption of lounges, bars … (where) people can feel comfortable.”

  Despite technological advances and modern branding efforts, it remains to be seen how keen consumers will be to incorporate CBD or THC beverages into their lifestyles in a more regular manner.

  Beverage makers are encouraged by what’s ahead of them, but for now the demand for cannabis beverages doesn’t match the output of effort from those within the industry.

  Don’t forget to follow us?@INN_Cannabis?for real-time updates!

  Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

  Editorial Disclosure: BevCanna Enterprises is a client of the Investing News Network. This article is not paid-for content.

  The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  Keep reading…

  Show less

  Investing News Network

  July 07 | 2021

  In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

  – The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

  – The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus an average of 4 cycles per year for conventional Cannabis cultivation.

  – The Company is on track to reach commercialization in H1/2022.

  VANCOUVER, BC and REHOVOT, Israel , July 7, 2021 /PRNewswire/ — BioHarvest Sciences Inc. (“BioHarvest” or the “Company”)?(CSE: BHSC) today announces it has reached a significant milestone in its production of Cannabinoids, with its first cell reservoir producing Cannabis Trichomes (the natural micro-factories producing Cannabinoids) for the past two years. This achievement demonstrates the efficiency and reliability of the Company’s BioFarming technology to produce the “flowering” stage of the Cannabis growth cycle at scale, which is significantly shorter, more productive, and cost-efficient, and more environmentally sustainable than conventional Cannabis cultivation.

  BioHarvest’s ground-breaking technology employs the original Cannabis plant and its respective cells as starting material only once, allowing the Company to harvest 13-17 cycles per year versus an average of 4 cycles per year for conventional Cannabis cultivation. The Company’s bioreactors can reliably and continuously produce Cannabis cells without the need to source the mother plant, seeds, or any other starting material again. This efficiency results from bypassing the “seeding” and “vegetative” stage, usually taking a Cannabis plant anywhere between 6 and 13 weeks.

  In addition, BioHarvest’s Cannabis cells are able to remain in the flowering stage continuously, in contrast to a typical Cannabis flower that will terminate after 9 or 10 weeks of flowering and will be immediately followed by the end of the plant’s life cycle. In that case, new starting material will need to be sourced and propagated, and new seedlings will be required to be grown through the vegetative stage, once again. BioHarvest’s BioFarming technology does not require the conventional propagation and vegetative stages and provides an unprecedented level of efficiency and consistency to the Cannabis industry.

  BioHarvest Cannabis BioFarming Life Cycle (PRNewsfoto/BioHarvest Sciences Inc.)

  ” The repeated use of the same Cannabis cell reservoir for two years is an unprecedented scientific achievement in the Cannabis plant kingdom ,” said Dr. Yochi Hagay , BioHarvest CTO.? ” Our ability to keep our Cannabis cells in this “flowering” stage for the past two years versus conventional periods of nine weeks demonstrates the unique efficiency of our technology and puts us on track to reach commercial production using Cannabis-based compounds .”

  Ilan Sobel , the CEO, said: ” The Company is on track to commercialize its Cannabis-based products in H1/2022. The abilities and achievements discussed above take us closer to such a time when we can bring the power of the Company’s BioFarming technology to the Cannabis market. I am pleased with our progress and shall continue to update BHSC’s stakeholders periodically .”

  Eitan Popper , Co-Founder and former President of MedReleaf, and Chairman of BioHarvest’s Board of Advisors, stated: ” The fact that BioHarvest has been able to use the same cell reservoir for two years now, is a testament to the robustness of the Company’s technology and the quality of its Standard Operating Procedures. Reducing the growth cycle and total production time from no less than the conventional 16 weeks to 3-4 weeks, has immense economic and environmental implications. ”

  The Company invites all interested investors and media to join the July 8 Shareholder Update Webinar, at 2pm EST . Register Now!

  https://app.livestorm.co/st-financial/bioharvest-sciences-q2-shareholder-update-july-8-2021?type=detailed

  About BioHarvest Sciences Inc.

  Based in Vancouver BC,?BioHarvest Sciences Inc.?is the?developer and exclusive owner?of the proprietary and patent-protected?BioFarming?technology. It is the first and only industrial-scale?plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself.?The Company’s technology is non-GMO and has already been validated by?VINIA?, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA? and other Super Fruit Nutraceutical products. Further, by adapting?this technology to the cannabis plant,?and building adequate production capacity,?BioHarvest Sciences Inc.‘s objective is to also become a leading supplier of cannabis for both medicinal and legal recreational purposes. For more information?visit: www.bioharvest.com .

  BioHarvest Sciences Inc.

  Ilan Sobel , Chief Executive Officer

  For further information, please contact:

  Dave Ryan , VP Investor Relations & Director

  Phone: 1 (604) 622-1186

  Email: dave@bioharvest.com

  Media Contact

  Will Hummel

  +31639177280

  William.Hummel@BOLDTpartners.com

  Forward-Looking Statements

  Information set forth in this news release includes might include forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, there is no assurance we will be able to commercialize our first Cannabis products in the first half of 2022. Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. The success of the Company in demonstrating its ability to consistently grow in solution trichomes from multiple plant strains is not an assurance that the Company will be able to commence commercial production when anticipated or at all. While the company is in the process of constructing a two ton production facility the Company ‘s current licensing only permits scientific research. Projected sales of Cannabis will require the company to obtain production and / or export licensing which cannot be assured.

  All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.

  Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

  Photo – https://www.brrq.net/wp-content/uploads/2021/07/3AAK1pUF.jpg

  Logo – https://www.brrq.net/wp-content/uploads/2021/07/4OSNrnYS.jpg

  (PRNewsfoto/BioHarvest Sciences Inc.)

  Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/bioharvest-sciences-incs-first-cannabis-cell-reservoir-produces-ongoing-flowering-stage-cannabinoid-cells-for-2-years-301326388.html

  SOURCE BioHarvest Sciences Inc.

  

  News Provided by PR Newswire via QuoteMedia

  Request an Investor Kit:

  Include me in the Accredited Investor email list

  Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for “accredited investor” in the search bar above.

  By completing this form, you are giving consent to receive communication from BioHarvest Sciences using the contact information you provide. And remember you can unsubscribe at any time.

  Keep reading…

  Show less

  Investing News Network

  July 07 | 2021

  Trulieve is the first medical cannabis operator to start planting in the state

  Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

  ” West Virginia patients have been waiting on medical cannabis for some time, and we are happy to announce we have planted our first crop,” said Trulieve Chief Executive Officer Kim Rivers .? “As we have demonstrated in our home state of Florida , Trulieve is dedicated to providing meaningful access to patients. We look forward to introducing the Trulieve brand in the state, providing patients with the highest quality products to meet their medical needs.”

  As of June 30, 2021 , the state of West Virginia has 2,305 patients enrolled in their medical cannabis program, meeting the deadline for three-year registration. Those who register by September 30 th will be eligible for two years, and after October 1 st will be eligible for a one-year card.?For more information visit http://www.medcanwv.org .

  Trulieve?is committed to investing in the communities it operates in and is approaching?West Virginia?with the same high level of integrity, focusing on diversity, equity, and inclusion, and dedication to a variety of quality products. ?Trulieve is currently hiring for numerous roles in West Virginia . Please visit https://www.trulieve.com/community-outreach/careers to learn more.

  About Trulieve

  Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also holds licenses to operate in California , Massachusetts , Pennsylvania , Connecticut , and West Virginia . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF .

  To learn more about Trulieve, visit www.Trulieve.com .

  Cision View original content: https://www.prnewswire.com/news-releases/trulieve-announces-start-of-operations-in-west-virginia-301326773.html

  SOURCE Trulieve Cannabis Corp.

  

  Cision View original content: http://www.newswire.ca/en/releases/archive/July2021/07/c3417.html

  News Provided by Canada Newswire via QuoteMedia

  Cannabis Free Report Cover

  ?

  ?

  Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

  ?

  Grab Your Report Today!

  Keep reading…

  Show less

  Investing News Network

  July 07 | 2021

  – The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

  – The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

  – The Company is on track to reach commercialization in H1/2022.

  BioHarvest Sciences Inc. (“BioHarvest” or the “Company”)?(CSE: BHSC) today announces it has reached a significant milestone in its production of Cannabinoids, with its first cell reservoir producing Cannabis Trichomes (the natural micro-factories producing Cannabinoids) for the past two years. This achievement demonstrates the efficiency and reliability of the Company’s BioFarming technology to produce the “flowering” stage of the Cannabis growth cycle at scale, which is significantly shorter, more productive, and cost-efficient, and more environmentally sustainable than conventional Cannabis cultivation.

  BioHarvest’s groundbreaking technology employs the original Cannabis plant and its respective cells as starting material only once, allowing the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture. The Company’s bioreactors can reliably and continuously produce Cannabis cells without the need to source the mother plant, seeds, or any other starting material again. This efficiency results from bypassing the “vegetative” stage, usually taking a Cannabis plant anywhere between 5 and 13 weeks.

  In addition, BioHarvest’s Cannabis cells are able to remain in the flowering stage continuously, in contrast to a typical Cannabis flower that will terminate after 9 or 10 weeks of flowering and will be immediately followed by the end of the plant’s life cycle. In that case, new starting material will need to be sourced and propagated, and new seedlings will be required to be grown through the vegetative stage, once again. BioHarvest’s BioFarming technology provides an unprecedented level of efficiency and consistency to the Cannabis industry.

  BioHarvest Cannabis BioFarming Life Cycle (PRNewsfoto/BioHarvest Sciences Inc.)

  ” The repeated use of the same Cannabis cell reservoir for two years is an unprecedented scientific achievement in the Cannabis plant kingdom ,” said Dr. Yochi Hagay , BioHarvest CTO.? ” Our ability to keep our Cannabis cells in this “flowering” stage for the past two years versus conventional periods of nine weeks demonstrates the unique efficiency of our technology and puts us on track to reach commercial production using Cannabis-based compounds .”

  Ilan Sobel , the CEO, said: ” The Company is on track to commercialize its Cannabis-based products in H1/2022. The abilities and achievements discussed above take us closer to such a time when we can bring the power of the Company’s BioFarming technology to the Cannabis market. I am pleased with our progress and shall continue to update BHSC’s stakeholders periodically .”

  Eitan Popper , Co-Founder and former President of MedReleaf, and Chairman of BioHarvest’s Board of Advisors, stated: ” As an executive who dealt extensively for years with the various stages of the growth of the Cannabis plant using conventional agriculture, one can look with a lot of excitement at the potential impact of the BioFarming technology. Such evidence demonstrated by the Company indicates that BioFarming brings significant value to the Cannabis market in efficiency and consistency among many other attributes. ”

  The Company invites all interested investors and media to join the July 8 Shareholder Update Webinar, at 2pm EST . Register Now!

  https://app.livestorm.co/st-financial/bioharvest-sciences-q2-shareholder-update-july-8-2021?type=detailed

  About BioHarvest Sciences Inc.

  Based in Vancouver BC,?BioHarvest Sciences Inc.?is the?developer and exclusive owner?of the proprietary and patent-protected?BioFarming?technology. It is the first and only industrial-scale?plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself.?The Company’s technology is non-GMO and has already been validated by?VINIA?, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA? and other Super Fruit Nutraceutical products. Further, by adapting?this technology to the cannabis plant,?and building adequate production capacity,?BioHarvest Sciences Inc.‘s objective is to also become a leading supplier of cannabis for both medicinal and legal recreational purposes. For more information?visit: www.bioharvest.com .

  Forward-Looking Statements

  Information set forth in this news release includes might include forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In particular, there is no assurance we will be able to commercialize our first Cannabis products in the first half of 2022. Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. The success of the Company in demonstrating its ability to consistently grow in solution trichomes from multiple plant strains is not an assurance that the Company will be able to commence commercial production when anticipated or at all. While the company is in the process of constructing a two ton production facility the Company ‘s current licensing only permits scientific research. Projected sales of Cannabis will require the company to obtain production and / or export licensing which cannot be assured.

  All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.

  Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

  Photo – https://www.brrq.net/wp-content/uploads/2021/07/3AAK1pUF.jpg

  Logo – https://www.brrq.net/wp-content/uploads/2021/07/4OSNrnYS.jpg

  (PRNewsfoto/BioHarvest Sciences Inc.)

  Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/bioharvest-sciences-incs-first-cannabis-cell-reservoir-produces-ongoing-flowering-stage-cannabinoid-cells-for-2-years-301326388.html

  SOURCE BioHarvest Sciences Inc.

  

  Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/July2021/07/c9588.html

  News Provided by Canada Newswire via QuoteMedia

  Request an Investor Kit:

  Include me in the Accredited Investor email list

  Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for “accredited investor” in the search bar above.

  By completing this form, you are giving consent to receive communication from BioHarvest Sciences using the contact information you provide. And remember you can unsubscribe at any time.

  Keep reading…

  Show less